sunitinib malate

Generic: sunitinib malate

Labeler: mylan pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name sunitinib malate
Generic Name sunitinib malate
Labeler mylan pharmaceuticals inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

sunitinib malate 37.5 mg/1

Manufacturer
Mylan Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 0378-6681
Product ID 0378-6681_9e441770-fe62-43c0-b293-7ebc8f753ebc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA201275
Listing Expiration 2026-12-31
Marketing Start 2022-01-04

Pharmacologic Class

Classes
kinase inhibitor [epc] protein kinase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 03786681
Hyphenated Format 0378-6681

Supplemental Identifiers

RxCUI
616279 616285 616289 1541890
UNII
LVX8N1UT73

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name sunitinib malate (source: ndc)
Generic Name sunitinib malate (source: ndc)
Application Number ANDA201275 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 37.5 mg/1
source: ndc
Packaging
  • 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-6681-28)
source: ndc

Packages (1)

Ingredients (1)

sunitinib malate (37.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "9e441770-fe62-43c0-b293-7ebc8f753ebc", "openfda": {"unii": ["LVX8N1UT73"], "rxcui": ["616279", "616285", "616289", "1541890"], "spl_set_id": ["4dbfcc02-dacc-4f0c-9f41-095783b68e27"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "28 CAPSULE in 1 BOTTLE, PLASTIC (0378-6681-28)", "package_ndc": "0378-6681-28", "marketing_start_date": "20220104"}], "brand_name": "Sunitinib Malate", "product_id": "0378-6681_9e441770-fe62-43c0-b293-7ebc8f753ebc", "dosage_form": "CAPSULE", "pharm_class": ["Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "0378-6681", "generic_name": "sunitinib malate", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sunitinib Malate", "active_ingredients": [{"name": "SUNITINIB MALATE", "strength": "37.5 mg/1"}], "application_number": "ANDA201275", "marketing_category": "ANDA", "marketing_start_date": "20220104", "listing_expiration_date": "20261231"}